{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:37:14Z","timestamp":1791319034314,"version":"4.3.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["308723\/2013-9"],"award-info":[{"award-number":["308723\/2013-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["449436\/2014-4"],"award-info":[{"award-number":["449436\/2014-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de Ensino Superior"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.pharep.2016.05.010","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T10:45:56Z","timestamp":1468665956000},"page":"996-1001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Antidepressant-like effects of ascorbic acid and ketamine involve modulation of GABAA and GABAB receptors"],"prefix":"10.1007","volume":"68","author":[{"given":"Priscila B.","family":"Rosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian B.","family":"Neis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille M.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgana","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6285-8780","authenticated-orcid":false,"given":"Ana L\u00facia S.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2016.05.010_bib0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/475027a","article-title":"Grand challenges in global mental health","volume":"475","author":"Collins","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pharep.2016.05.010_bib0010","first-page":"3","article-title":"The increasing burden of depression","volume":"7","author":"Lepine","year":"2011","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.pharep.2016.05.010_bib0015","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0022-3999(02)00309-4","article-title":"Depression and immune function: central pathways to morbidity and mortality","volume":"53","author":"Kiecolt-Glaser","year":"2002","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.pharep.2016.05.010_bib0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.brainresrev.2009.05.005","article-title":"Emerging role of glutamate in the pathophysiology of major depressive disorder","volume":"61","author":"Hashimoto","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pharep.2016.05.010_bib0025","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tips.2009.09.002","article-title":"Glutamate-based antidepressants: 20 years on","volume":"30","author":"Skolnick","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharep.2016.05.010_bib0030","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharep.2016.05.010_bib0035","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/DDDT.S62912","article-title":"Altered gamma-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants","volume":"9","author":"Pehrson","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.pharep.2016.05.010_bib0040","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1176\/appi.ajp.159.4.663","article-title":"Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors","volume":"159","author":"Sanacora","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharep.2016.05.010_bib0045","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1176\/appi.ajp.160.3.577","article-title":"Increased cortical GABA concentrations in depressed patients receiving ECT","volume":"160","author":"Sanacora","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharep.2016.05.010_bib0050","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.pharep.2016.05.010_bib0055","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.eurpsy.2013.10.005","article-title":"Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex","volume":"29","author":"Zhou","year":"2014","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.pharep.2016.05.010_bib0060","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","article-title":"Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure","volume":"69","author":"Li","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharep.2016.05.010_bib0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pnpbp.2013.11.003","article-title":"Ketamine reverses stress-induced depression-like behavior and increased GABA levels in the anterior cingulate: an 11.7T 1H-MRS study in rats","volume":"51","author":"Perrine","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharep.2016.05.010_bib0070","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/mp.2015.83","article-title":"A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder","volume":"21","author":"Milak","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharep.2016.05.010_bib0075","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0301-0082(94)90052-3","article-title":"A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission","volume":"43","author":"Rebec","year":"1994","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharep.2016.05.010_bib0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0166-2236(99)01543-X","article-title":"Ascorbate regulation and its neuroprotective role in the brain","volume":"23","author":"Rice","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharep.2016.05.010_bib0085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1179\/135100003225003393","article-title":"Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors","volume":"8","author":"Khanzode","year":"2003","journal-title":"Redox Rep"},{"key":"10.1016\/j.pharep.2016.05.010_bib0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00213-001-0929-6","article-title":"A randomized controlled trial of high dose ascorbic acid for reduction of blood pressure, cortisol, and subjective responses to psychological stress","volume":"159","author":"Brody","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharep.2016.05.010_bib0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1475-2891-12-31","article-title":"Efficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double-blind, placebo-controlled pilot study","volume":"12","author":"Amr","year":"2013","journal-title":"Nutr J"},{"key":"10.1016\/j.pharep.2016.05.010_bib0100","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.pnpbp.2009.02.003","article-title":"Ascorbic acid administration produces an antidepressant-like effect: Evidence for the involvement of monoaminergic neurotransmission","volume":"33","author":"Binfar\u00e9","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharep.2016.05.010_bib0105","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.euroneuro.2015.03.006","article-title":"TNF-alpha-induced depressive-like phenotype and p38(MAPK) activation are abolished by ascorbic acid treatment","volume":"25","author":"Moretti","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2016.05.010_bib0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpsychires.2013.10.014","article-title":"Antidepressant-like effect of ascorbic acid is associated with the modulation of mammalian target of rapamycin pathway","volume":"48","author":"Moretti","year":"2014","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pharep.2016.05.010_bib0115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11302-015-9446-7","article-title":"Creatine, similarly to ketamine, affords antidepressant-like effects in the tail suspension test via adenosine A1 and A2A receptor activation","volume":"11","author":"Cunha","year":"2015","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.pharep.2016.05.010_bib0120","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharep.2016.05.010_bib0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pbb.2014.12.009","article-title":"Agmatine enhances antidepressant potency of MK-801 and conventional antidepressants in mice","volume":"130","author":"Neis","year":"2015","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharep.2016.05.010_bib0130","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1542\/peds.65.4.862","article-title":"Antidepressant effect of vitamin C","volume":"65","author":"Cocchi","year":"1980","journal-title":"Pediatrics"},{"key":"10.1016\/j.pharep.2016.05.010_bib0135","first-page":"9","article-title":"Nutrition and depressive symptoms in community-dwelling elderly persons in Japan","volume":"63","author":"Oishi","year":"2009","journal-title":"Acta Med Okayama"},{"key":"10.1016\/j.pharep.2016.05.010_bib0140","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbr.2011.07.024","article-title":"Involvement of nitric oxide-cGMP pathway in the antidepressant-like effect of ascorbic acid in the tail suspension test","volume":"225","author":"Moretti","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharep.2016.05.010_bib0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbr.2010.10.009","article-title":"Antidepressant-like properties of \u03b12-containing GABAA receptors","volume":"217","author":"Vollenweider","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharep.2016.05.010_bib0150","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0031-9384(90)90339-6","article-title":"Behavior of streptozotocin-diabetic mice in tests of exploration, locomotion, anxiety, depression and aggression","volume":"48","author":"Hilakivi-Clarke","year":"1990","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharep.2016.05.010_bib0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbr.2015.01.018","article-title":"Antidepressant dose of taurine increases mRNA expression of GABAA receptor \u03b12 subunit and BDNF in the hippocampus of diabetic rats","volume":"283","author":"Caletti","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharep.2016.05.010_bib0160","doi-asserted-by":"crossref","first-page":"8106","DOI":"10.1073\/pnas.1414728112","article-title":"Optogenetic stimulation of infralimbic PFC reproduces ketamine's rapid and sustained antidepressant actions","volume":"112","author":"Fuchikami","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharep.2016.05.010_bib0165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/YCT.0000000000000148","article-title":"Effects of low-dose ketamine combined with propofol on phosphorylation of AMPA receptor GluR1 subunit and GABAA receptor in hippocampus of stressed rats receiving electroconvulsive shock","volume":"31","author":"Chen","year":"2015","journal-title":"J ECT"},{"key":"10.1016\/j.pharep.2016.05.010_bib0170","doi-asserted-by":"crossref","first-page":"15653","DOI":"10.1073\/pnas.0507901102","article-title":"Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression","volume":"102","author":"Choudary","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharep.2016.05.010_bib0175","doi-asserted-by":"crossref","first-page":"e6585","DOI":"10.1371\/journal.pone.0006585","article-title":"Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression","volume":"4","author":"Sequeira","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.pharep.2016.05.010_bib0180","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/npp.2015.112","article-title":"Rapid antidepressant action and restoration of excitatory synaptic strength after chronic stress by negative modulators of Alpha5-Containing GABAA Receptors","volume":"40","author":"Fischell","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharep.2016.05.010_bib0185","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrn3249","article-title":"Regulation of neuronal GABAB receptor functions by subunit composition","volume":"13","author":"Gassmann","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharep.2016.05.010_bib0190","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tips.2004.11.004","article-title":"Don\u2019t worry \u2018B\u2019 happy!: a role for GABAB receptors in anxiety and depression","volume":"26","author":"Cryan","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharep.2016.05.010_bib0195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brainres.2004.05.053","article-title":"Immunocytochemical localization of GABABR1 receptor subunits in the basolateral amygdala","volume":"1018","author":"McDonald","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharep.2016.05.010_bib0200","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1471-4159.2009.06229.x","article-title":"Subcellular compartment-specific molecular diversity of pre- and post-synaptic GABA-activated GIRK channels in Purkinje cells","volume":"110","author":"Fernandez-Alacid","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharep.2016.05.010_bib0205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1054-3589(10)58010-4","article-title":"GABAB receptors: physiological functions and mechanisms of diversity","volume":"58","author":"Pinard","year":"2010","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.pharep.2016.05.010_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1476-5381.2010.01004.x","article-title":"The GABAB receptor as a target for antidepressant drug action","volume":"162","author":"Ghose","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2016.05.010_bib0215","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1054-3589(10)58002-5","article-title":"Chemistry and pharmacology of GABAB receptor ligands","volume":"58","author":"Froestl","year":"2010","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.pharep.2016.05.010_bib0220","first-page":"208","article-title":"A GABAB mystery: the search for pharmacologically distinct GABAB receptors","volume":"1","author":"Enna","year":"2001","journal-title":"Mol Interv"},{"key":"10.1016\/j.pharep.2016.05.010_bib0225","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.bcp.2004.07.033","article-title":"Six decades of GABA","volume":"68","author":"Bowery","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharep.2016.05.010_bib0230","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/sj.npp.1300413","article-title":"Genetic and pharmacological evidence of a role for GABAB receptors in the modulation of anxiety- and antidepressant-like behavior","volume":"29","author":"Mombereau","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharep.2016.05.010_bib0235","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00001756-200502280-00021","article-title":"Altered anxiety and depression-related behaviour in mice lacking GABAB(2) receptor subunits","volume":"16","author":"Mombereau","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharep.2016.05.010_bib0240","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.neuropharm.2012.06.066","article-title":"Blockade of the GABAB receptor increases neurogenesis in the ventral but not dorsal adult hippocampus: relevance to antidepressant action","volume":"63","author":"Felice","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharep.2016.05.010_bib0245","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/sj.bjp.0706845","article-title":"Antidepressant-like activity of CGP 36742 and CGP 51176, selective GABAB receptor antagonists, in rodents","volume":"149","author":"Nowak","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharep.2016.05.010_bib0250","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1113\/jphysiol.2014.281378","article-title":"GABAB receptor-mediated tonic inhibition regulates the spontaneous firing of locus coeruleus neurons in developing rats and in citalopram-treated rats","volume":"593","author":"Wang","year":"2014","journal-title":"J Physiol"},{"key":"10.1016\/j.pharep.2016.05.010_bib0255","doi-asserted-by":"crossref","first-page":"15232","DOI":"10.1073\/pnas.1404090111","article-title":"GABAB(1) receptor subunit isoforms differentially regulate stress resilience","volume":"111","author":"O\u2019Leary","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharep.2016.05.010_bib0260","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.pharep.2015.10.006","article-title":"The Role of glutamatergic, GABA-ergic, and cholinergic receptors in depression and antidepressant-like effect","volume":"68","author":"Pytka","year":"2016","journal-title":"Pharmacol Rep"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016300500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016300500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:33Z","timestamp":1752611793000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2016.05.010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1734114016300500"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2016.05.010","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant-like effects of ascorbic acid and ketamine involve modulation of GABAA and GABAB receptors","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2016.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}